Promoter Methylation Status of Breast Cancer Susceptibility Gene 1 and 17 Beta Hydroxysteroid Dehydrogenase Type 1 Gene in Sporadic Breast Cancer Patients

Epigenetic modifications are involved in breast carcinogenesis. Identifying genes that are epigenetically silenced via methylation could select target patients for diagnostic as well as therapeutic potential. We assessed promoter methylation of breast cancer susceptibility gene 1 (BRCA1) and 17 Beta...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosny, Marwa M., Sabek, Nagwan A., El-Abaseri, Taghrid B., Hassan, Fathalla M., Farrag, Sherif H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931089/
https://www.ncbi.nlm.nih.gov/pubmed/27413552
http://dx.doi.org/10.1155/2016/9545241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931089/
https://www.ncbi.nlm.nih.gov/pubmed/27413552
http://dx.doi.org/10.1155/2016/9545241

Ejemplares similares